Loading...
Options B.R.O.
Example search prompt
Example search prompt
Example search prompt
Example search prompt
The Indian equity market faced significant selling pressure on March 11, pulling benchmark indices to their lowest levels in nearly a year. The Nifty 50 fell below the 23,900 mark intraday, reflecting cautious investor sentiment across sectors.After a modest rebound in the previous session, marke...
The Indian stock market faced a sharp correction on March 2, as investors reacted to rising geopolitical tensions between the US and Iran. The Sensex tumbled over 1,000 points, while the Nifty slipped below the 24,900 mark, reflecting a wave of cautious sentiment across the broader market.Global ...
Market PerformanceThe latest Sensex and Nifty News paints a cautious picture for Dalal Street.On February 27, Indian benchmark indices ended sharply lower. The selling pressure was not limited to one pocket. It was broad and persistent.At closing bell:Sensex fell 961.42 points or 1.17% to settle ...
Q3 FY26 Performance SnapshotThe Indian pharma sector delivered a steady Q3 FY26, with performance largely driven by domestic strength.Sales Growth: +13% YoYOperating Profit: +12% YoYPAT Growth: +1% YoYWhile revenue and operating profit expanded in tandem, net profit growth remained muted due to m...
Indian equity markets could not hold on to early gains on February 18, as both the Sensex and Nifty ended sharply lower, breaking a three-day winning streak. The Nifty slipped below the 25,500-mark, with profit booking and broad-based selling dragging the indices down.Market PerformanceThe day st...
The Indian stock market extended its upward momentum for the third consecutive session on Tuesday, February 10. Both the Sensex and Nifty 50 posted healthy gains, driven by positive global cues and robust domestic sentiment. Investors across segments witnessed broad-based support, boosting market...
India’s largest domestic institutional investor, Life Insurance Corporation of India (LIC), has completed a significant portfolio rejig in the quarter ended December 2025. The insurer actively adjusted its holdings, trimming stakes in some companies while increasing exposure in others. These move...
The Nifty 50 trading strategy remains in focus as Indian equities extended their upward move for the third straight session. Tuesday’s trade showed steady confidence, with benchmark indices holding on to gains and buyers staying active near record territory.The broader mood stayed positive, suppo...
Indian American Depositary Receipts (ADRs) listed on Nasdaq and the New York Stock Exchange witnessed a sharp surge on Monday after a major US-India trade announcement. The US government agreed to reduce the reciprocal tariffs on Indian goods from 50% to 18%, marking a significant improvement in ...
The Indian stock market witnessed a strong bounce on Thursday, January 22, 2026, as investors returned to the market following a brief period of selling pressure. Positive global cues, along with easing geopolitical tensions, created an upbeat mood on the trading floor, giving both the Sensex and...
The Indian stock market witnessed a cautious trading session on Wednesday, December 24, as investors booked profits in select heavyweights amid mixed global cues. The benchmark Sensex slipped 116 points, or 0.14%, to settle at 85,408.70. Similarly, the Nifty 50 closed at 26,142.10, down 35 points...
Indian equity markets lost momentum in the second half of Wednesday’s trade. After starting the session on a steady note, both benchmark indices slipped from their intraday highs as selling pressure quietly crept back in.By afternoon trade, the mood had turned cautious. Profit-booking emerged in ...
Stocks to Watch Today: RIL, Kotak Bank, Dr Reddy’s, Ola Electric, Coforge, and MoreSeveral major companies are in focus as markets open today, including Reliance Industries, Kotak Mahindra Bank, Dr Reddy’s Laboratories, Ola Electric, Coforge, and SBI Cards. These developments come amid quarterly ...
Stocks to Watch Today: PNB, BEL, Tata Motors, Dr Reddy’s in FocusSeveral major Indian companies are expected to be in focus today following key corporate developments, including stake sales, order wins, regulatory approvals, and festive performance updates. Among the stocks to watch today are Pun...
Market PerformanceThe Indian stock market extended its positive momentum as both Sensex and Nifty closed higher for the sixth consecutive session on Thursday, August 21.Sensex gained 143 points (0.17%) to close at 82,000.71Nifty 50 rose 33 points (0.13%) to settle at 25,083.75However, gains remai...
Market PerformanceThe Nifty Pharma Index rose 1.9% during intraday trades on Wednesday, marking a strong relief rally in the Indian stock market.Opening level: 21,803.45Previous close: 21,753.50Intraday high: 22,171.05Leading the gains were Alkem Laboratories, Zydus Lifesciences, Laurus Labs, and...
Market PerformanceThe Indian stock market experienced a strong rally on Wednesday, following gains in global markets and a decline in domestic inflation.Sensex climbed 413.09 points (0.51%) to 80,648.68.Nifty 50 rose 161.15 points (0.66%) to 24,648.55 at 2 p.m.Midcap and small-cap indices outperf...
Market PerformanceOn Friday, August 8, the Indian stock market faced a sharp sell-off, wiping out significant investor wealth.Both Sensex and Nifty 50 ended the session nearly 1% lower, dragged down by rising trade tensions and global uncertainty.Sensex fell 765.47 points or 0.95% to close at 79,...
Market PerformanceDr Reddy’s Laboratories witnessed a notable upswing in its share price during early trade on July 24.Share Price Movement: The stock climbed 3%, reaching ₹1,288.Recent Trend: Despite the Q1 boost, the stock is down 10% YTD.Main NewsDr Reddy’s Laboratories released its financial ...
Market PerformanceOn July 21, 2025, Dr. Reddy’s Laboratories share price dipped in early trading hours following regulatory observations issued by the USFDA.Share Price at 09:27 AM: ₹1,250.35Day’s Decline: ₹7.75 or 0.62%52-Week High: ₹1,420.20 (21 August, 2024)52-Week Low: ₹1,025.90 (07 April, 20...
Market Performance: Sensex and Nifty End Higher on July 8On Tuesday, July 8, benchmark Indian indices — the Sensex and Nifty 50 — ended the trading session in positive territory, buoyed by gains in heavyweight financial stocks.Sensex climbed 270 points or 0.32% to finish at 83,712.51Nifty 50 adva...
Market PerformanceOn July 8, Indian pharmaceutical stocks experienced a notable dip in early trade as global trade tensions escalated. The Nifty Pharma index slipped nearly 1%, hovering around 22,159 during morning hours.This marked the second straight day of losses for the index, after an extend...
The Indian stock market bounced back on Friday, July 4, with benchmark indices — Sensex and Nifty 50 — closing modestly higher after a rangebound session. The gains were supported by heavyweight stocks, despite ongoing trade concerns and cautious investor sentiment.Market PerformanceSensex ended ...
India's benchmark indices—the Sensex and the Nifty 50—closed lower on Thursday, July 3, amid ongoing concerns around global cues, foreign fund outflows, and uncertainty in the India-US trade talks. Here's a detailed look at the day's market performance and highlights.Market PerformanceThe Sensex ...
Market PerformanceIndian stock markets witnessed a muted session on June 19, with frontline indices closing nearly flat as weak global signals and rising geopolitical tensions dulled investor appetite.Sensex ended 82.79 points lower or 0.10% at 81,361.87Nifty 50 fell 18.80 points or 0.08% to clos...
Market PerformanceIndian stock markets surged on June 16, with Sensex and Nifty snapping a two-day losing streak despite ongoing geopolitical tensions in West Asia.Sensex jumped 677 points or 0.84% to close at 81,796.15Nifty 50 gained 227.90 points or 0.92%, closing at 24,946.50Nifty Midcap 100 a...
Market PerformanceDespite a weak broader market on June 12, Nifty Pharma outshone as the only sectoral gainer, climbing nearly 1% to 22,243 in morning trade.This uptrend in pharma shares was primarily driven by easing global trade concerns after U.S. President Donald Trump's announcement regardin...
Market Performance: Tata Group Leads Nifty 50 RallyTata Group stocks have outperformed the market, with 18 Nifty 50 stocks surging up to 37% in just two months. Leading the rally:Tata Motors – Up 36.7%Tech Mahindra – Up 33.2%Trent – Up 29.6%TCS – Up 13.3%Other major gainers include Reliance Indus...
Market Performance: Pharma Stocks Bounce Back StronglyPharma stocks have staged a remarkable recovery since April 2025, with major players like Granules India, Gland Pharma, Dr. Reddy's Laboratories, Natco Pharma, Aurobindo Pharma, and Cipla leading the charge.Granules India surged 28% from ₹422 ...
Market PerformanceIndian stock markets extended gains on June 5, with the Sensex rising 443.94 points (0.55%) to 81,442.19 and the Nifty climbing 141.10 points (0.57%) to 24,761.30.Advancing Stocks: 2,023Declining Stocks: 1,479Unchanged Stocks: 121The India VIX, a volatility gauge, dropped 4.2% t...
Market PerformanceDr Reddy’s Laboratories (DRL) surged 4% to ₹1,303 on June 5, becoming the top gainer on the Nifty 50.The stock has climbed 9% over the past month, sharply outpacing the Nifty 50's modest 1% rise.Key Driver: Biosimilar Partnership with AlvotechDr Reddy’s Lab announced a strategic...
Market PerformanceThe Nifty Pharma Index plunged 1.92% in morning trade on Tuesday, sliding from Monday's close of 21,775.75 to an intraday low of 21,359.30.Opening level: 21,672.85Previous Close: 21,775.75Intraday low: 21,359.30Total dip: Approx. 2%This marked a notable fall in pharmaceutical st...
Market PerformanceDr Reddy's Laboratories Share Price surged by 2.90% in today's session, reaching Rs 1,142.60. The increase in share price was accompanied by a notable rise in trading volumes, signaling strong market interest and positive sentiment around the stock. This performance reflects the...
Market OverviewOn April 11, 2025, pharmaceutical shares witnessed a notable upswing following the temporary suspension of reciprocal tariffs by the United States. This development helped reduce recession-related concerns and contributed to optimism in the pharma sector. The Nifty Pharma index rec...
Market PerformanceShares of major Indian pharmaceutical companies increased by 3%- 13% in Thursday's trading session. This movement followed the announcement by U.S. President Donald Trump, who introduced reciprocal tariffs on multiple countries but did not specify any new duties for the pharmace...
Market PerformanceOn March 26, 2025, equity benchmark indices Sensex and Nifty declined over 1% after a seven-session rally. This downturn was attributed to investor profit booking and uncertainties surrounding US tariff policies.The Sensex opened positively, reaching an intraday high of 78,167.8...
Open Free Trading & Demat Account
Trusted by 5.5 Lakh+ Investors
By proceeding, you agree to our Privacy Policy and Terms and Conditions.
Easy & quick
1. Register on SCORES portal
2. Mandatory details for filling complaints on SCORES
Name | PAN | Address | Mobile | Number | E-mail ID
3. Benefits
Effective Communication
Speedy redressal of the grievances
